ST Germain D J Co. Inc. Raises Stock Holdings in Danaher Co. (NYSE:DHR)

ST Germain D J Co. Inc. grew its holdings in shares of Danaher Co. (NYSE:DHR) by 13.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,558 shares of the conglomerate’s stock after purchasing an additional 433 shares during the quarter. ST Germain D J Co. Inc.’s holdings in Danaher were worth $817,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Teachers Insurance & Annuity Association of America purchased a new stake in shares of Danaher during the 3rd quarter valued at about $39,000. MidAtlantic Capital Management Inc. purchased a new stake in shares of Danaher during the 3rd quarter valued at about $40,000. FSA Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter valued at about $50,000. Darwin Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter valued at about $55,000. Finally, Dunhill Financial LLC increased its position in shares of Danaher by 45.1% during the 3rd quarter. Dunhill Financial LLC now owns 222 shares of the conglomerate’s stock valued at $62,000 after purchasing an additional 69 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on DHR. TD Cowen boosted their price objective on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research note on Thursday, October 31st. Citigroup cut their price objective on Danaher from $305.00 to $285.00 and set a “buy” rating for the company in a research note on Monday, January 6th. UBS Group cut their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Finally, Royal Bank of Canada cut their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $286.80.

Danaher Stock Down 1.3 %

NYSE DHR opened at $235.08 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market capitalization of $169.79 billion, a P/E ratio of 44.86, a P/E/G ratio of 4.33 and a beta of 0.83. Danaher Co. has a one year low of $222.53 and a one year high of $281.70. The stock has a 50 day moving average price of $235.67 and a 200-day moving average price of $253.73.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.02 EPS. As a group, equities analysts predict that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.46%. Danaher’s payout ratio is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.